This Friday, the U.S. Food and Drug Administration will hear from an expert panel about the merits of, flibanserin, a drug that has been touted as potentially being the female equivalent of Viagra. Yet, an initial FDA review posted online today already indicates that Boehringer Ingelheim Pharmaceuticals, the manufacturer of flibanserin,

…